Cargando…
Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim
BACKGROUND: A common approach to cancer therapy in clinical practice is the combination of several drugs to boost the anticancer activity of available drugs while suppressing their unwanted side effects. In this regard, we examined the efficacy of combination treatment with the widely-used genotoxic...
Autores principales: | Park, Hye-Kyung, Lee, Ji-Eun, Lim, Jaehwa, Jo, Da-Eun, Park, Soo-Ah, Suh, Pann-Ghill, Kang, Byoung Heon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072609/ https://www.ncbi.nlm.nih.gov/pubmed/24927938 http://dx.doi.org/10.1186/1471-2407-14-431 |
Ejemplares similares
-
Mitochondrial Hsp90s suppress calcium-mediated stress signals propagating from mitochondria to the ER in cancer cells
por: Park, Hye-Kyung, et al.
Publicado: (2014) -
O-GlcNAcylation in health and neurodegenerative diseases
por: Lee, Byeong Eun, et al.
Publicado: (2021) -
Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim
por: Iyoda, Takuya, et al.
Publicado: (2016) -
O‐GlcNAcylation regulates lysophosphatidic acid‐induced cell migration by regulating ERM family proteins
por: Song, Minseok, et al.
Publicado: (2022) -
The Role of Phospholipase C in GABAergic Inhibition and Its Relevance to Epilepsy
por: Kim, Hye Yun, et al.
Publicado: (2021)